Why the study?
Does the Systemic Immune-Inflammation Index predict impaired myocardial perfusion and short-term mortality in STEMI patients undergoing primary PCI?
Does the Systemic Immune-Inflammation Index predict impaired myocardial perfusion and short-term mortality in STEMI patients undergoing primary PCI?
Higher Systemic Immune-Inflammation Index (SII) levels independently predict the no-reflow phenomenon and 30-day mortality in STEMI patients undergoing primary PCI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vatan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: